Hollander W, Paddock J, Colombo M A
Prog Biochem Pharmacol. 1977;13:123-33.
The accumulation of cholesterol in atherosclerotic lesions is associated with an increased uptake of plasma cholesterol and LDL by the arterial wall. During the regression of atherosclerosis, the uptake of these macromolecules returns to or below normal, suggesting that the retention of cholesterol in regressed lesions is due to a defect in the removal of cholesterol from the arterial wall rather than to an abnormality in vascular permeability. Although increased amounts of 125I-LDL were detected in atherosclerotic vessels, the percent distribution and fractional degradation rate of 125I-LDL appeared similar in normal and diseased vessels. The present studies in support of earlier findings in human vessels indicate that LDL in the artery is contained in a number of different cellular and extracellular pools in close association with AMPS. These lipoproteins appeared to be derived not only from the lipoproteins contained in the plasma but also from lipoproteins synthesized by the arterial wall.
动脉粥样硬化病变中胆固醇的积累与动脉壁对血浆胆固醇和低密度脂蛋白(LDL)摄取增加有关。在动脉粥样硬化消退过程中,这些大分子的摄取恢复到正常水平或低于正常水平,这表明消退病变中胆固醇的潴留是由于动脉壁胆固醇清除缺陷,而非血管通透性异常。尽管在动脉粥样硬化血管中检测到125I-LDL量增加,但正常血管和病变血管中125I-LDL的百分比分布和分数降解率似乎相似。目前支持人类血管早期研究结果的研究表明,动脉中的LDL存在于许多不同的细胞内和细胞外池中,并与氨基多糖(AMPS)密切相关。这些脂蛋白似乎不仅来源于血浆中的脂蛋白,还来源于动脉壁合成的脂蛋白。